September 21, 2016 – (Capricor) – “Capricor Therapeutics, Inc. today announced the closing of its previously announced underwritten registered public offering and concurrent registered direct offering. In the registered public offering, a total of 3,090,625 shares of the Company’s common stock were sold at an offering price of $3.20 per share. The shares include 403,125 shares of common stock sold pursuant to the underwriters’ over-allotment option, which option was exercised in full. In the registered direct offering, a total of 312,500 shares of the Company’s common stock were sold by Capricor directly to Cedars-Sinai Medical Center at a price of $3.20 per share.┬áRoth Capital Partners and National Securities Corporation, a wholly-owned subsidiary of National Holdings, Inc., (NASDAQ:NHLD) acted as joint book-running managers for the registered public offering.” Read Full Press Release